NCT04016246View on ClinicalTrials.gov

Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

March 18, 2024

Study Completion Date

October 31, 2026

Conditions
Respiratory Distress Syndrome in Premature Infant
Interventions
DRUG

Propofol-Lipuro

sedation of babies \< 32wGA with propofol / placebo before a LISA Procedure

DRUG

Placebos

injected to babies \< 32wGA with propofol / placebo before a LISA Procedure

Trial Locations (13)

10000

centre hospitalier deTroyes, Troyes

13000

Ap-H Marseille, Marseille

29200

Chu Brest, Brest

30000

Chu Nimes, Nîmes

35000

Ch Rennes, Rennes

38043

CHU Grenoble Alpes, Grenoble

44000

Chu Nantes, Nantes

49000

Chu Angers, Angers

73000

Chu Chambery, Chambéry

78300

Chi Poissy St Germain, Poissy

80000

Chu Amiens, Amiens

87000

Chu Limoges, Limoges

94000

Chi Creteil, Créteil

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER